J Clin Endocrinol Metab 104:47564768 Paccou J, Tsourdi E, Meier C, Palermo A, Pepe J, Body JJ, Zillikens MC (2022) Bariatric surgery and skeletal health: a narrative review and position statement for management by the European Calcified Tissue Society (ECTS)
If your ALT or AST levels change significantly, your prescribing provider should evaluate the context, considering whether you have baseline liver disease, how rapidly you are losing weight (rapid fat loss can temporarily increase liver enzyme release), and whether any concomitant medications could be contributing
There is no evidence to support regular calcitonin testing (a tumour marker for medullary thyroid carcinoma) or thyroid ultrasound surveillance in asymptomatic patients taking these medications
Tripathi A, Rankin J, Aarvold J, et al